Higher calorie refeeding of patients with anorexia nervosa appears no less safe than low calorie refeeding and leads to quicker stabilization.

Many of us do not think to ask about performance enhancing substances, and yet these are common and often hazardous to the health of our teen and young adult patients. Which ones are harmful? How do you ask about them? Learn here.

A randomized, double- blind, placebo-controlled trial studying the effects of olanzapine on change in body weight and obsessionality in adult outpatients with anorexia nervosa. Although strength of the study includes its large sample size, it is undetermined if patient weight gain is due to a therapeutic effect on anorexia or to olanzapine’s known metabolic effects.

Lisdexamfetamine (Vyvanse) is an extended release amphetamine-based stimulant that is approved for both ADHD and binge eating disorder (BED).

Few disorders frustrate clinicians as much as anorexia nervosa (AN). In the June 2015 issue of TCPR, we interviewed James Lock, who guided us through one of the few effective AN treatments, family-based therapy (FBT). In FBT, a family therapist works with the entire family to come up with a weight restoration plan for the patient.

James Lock, PhD, discusses his experiences treating children and adolescents with eating disorders. In the child psychiatry inpatient unit, among the kids with eating disorders, he saw that half or more were medically ill as a result of malnutrition or other behavioral problems that led to problems with electrolytes or blood pressures. His experiences eventually led him to treatment methods that involved families in an outpatient setting.

In January of this year, the FDA approved the stimulant lisdexamfetamine (Vyvanse) as the first drug with an indication for binge eating disorder (BED). Patients are hearing the buzz and may be asking you to prescribe it, but you may have some questions first.

Lisdexamfetamine (Vyvanse), a stimulant approved for treating kids and adults with ADHD, is the first drug approved by the US Food and Drug Administration (FDA) for treating adults with binge-eating disorder (BED).

...